Reversible Splenial Corpus Callosum Lesion and Carbamazepine
Reversible Splenial Corpus Callosum Lesion and Carbamazepine
Introductıon
Reversible splenial lesion syndrome (RESLES) at corpus callosum (CC) has been defined in many clinical conditions. Although the etiopathogenesis of transient focal lesions in the CC splenium has not been clarified, many theories remain on the agenda, especially in epilepsy patients.
Case
A 38-year-old male patient with idiopathic generalized epilepsy was admitted to the emergency department with complaints of frequent seizures. It was reported by his relatives that he had stopped carbamazepine treatment for the last three days. After his last epileptic attack, he had been headache, nausea, vomiting, decreased visual acuity, and prolonged confusion. The patient with diffusion restriction at the level of splenium CC in magnetic resonance imaging (MRI), whose seizure frequency increased, was evaluated by a neurology doctor. In his electroencephalography, spike waves were observed in both hemispheres, which were frequently generalized. The same lesion was not observed in the diffusion and MRI taken eight days later in the patient who had no seizures in the follow-up.
Discussion
Studies have shown that CC damage results in the disruption of cortical functions, with disconnection of the cerebral hemispheres and disturbances in consciousness. The clinical spectrum includes a fairly wide symptomatology. RESLES of the CC is an infrequent finding on MRI. Some of these lesions are associated with epileptic seizures, the sudden withdrawal of the antiepileptic drug, or usage.
Conclusion
RESLES, which we reviewed with etiology and clinical findings, still remains a mystery. It will be clarified with wide-ranging studies.
___
- Tetsuka S. Reversible lesion in the splenium of the corpus
callosum. Brain Behav. 2019 9;e01440. 10.1002/brb3.1440 .
- Jing C, Sun L, Wang Z, et al. Reversible splenial lesion
syndrome due to oxcarbazepine withdrawal: case report and
literature review. J Int Med Res. 2018; 46: 1277-1281.
- Blaauw J, Meiners LC. The splenium of the corpus
callosum: Embryology, anatomy, function, and imaging with pathophysiological hypothesis. Neuroradiology 2020;62:563–585.
- Notebaert A, Willems J, Coucke L, et al. Expanding the
spectrum of MERS type 2 lesions, a particular form of
encephalitis. Pediatr Neurol. 2013; 48: 135-138.
- Zhang S, Ma Y, Feng J. Clinicoradiological spectrum of
reversible splenial lesion syndrome (RESLES) in adults: a
retrospective study of a rare entity. Medicine (Baltimore)
2015;94: e512.
- Yuan J, Yang S, Wang S, et al. Mild encephalitis/encephalopathy
with reversible splenial lesion (MERS) in adults-a case report
and literature review. BMC Neurol. 2017; 17: 103.
- Dong K, Zhang Q, Ding J, et al. Mild encephalopathy with a
reversible splenial lesion mimicking transient ischemic attack:
a case report. Medicine (Baltimore) 2016; 95: e5258.
- Lu PI, Hodes JF, Zheng X, et al. Reversible Splenial
Lesion Syndrome with Some Novel Causes and Clinical
Manifestations. Intern. Med. 2020;59, 2471–2480.
- Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild
encephalitis/encephalopathy with a reversible splenial lesion.
Neurology 2004;63(10): 1854-1858. PMID: 15557501. DOI:
10.1212/01.wnl.0000144274.12174.cb
- Gurtler S, Ebner A, Tuxhorn I, et al. Transient lesion in the
splenium of the corpus callosum and antiepileptic drug
withdrawal. Neurology 2005;65:1032–1036.
Prilipko O, Delavelle J, Lazeyras F, et al. Reversible cytotoxic
edema in the splenium of the corpus callosum related to
antiepileptic treatment: report of two cases and literature
review. Epilepsia 2005;46: 1633-1636.
- Doherty MJ, Jayadev S, Watson NF, et al. Clinical implications
of splenium magnetic resonance imaging signal changes. Arch
Neurol 2005;62: 433-437.
- Öztoprak İ, Engin A, Gümüs C, et al. Transient splenial lesions
of the corpus callosum in different stages of evolution. Clin
Radiol 2007;62: 907-913.
- Da Rocha AJ, Reis F, Gama HP, et al. Focal transient lesion
in the splenium of the corpus callosum in three non-epileptic
patients. Neuroradiology 2006;48(10): 731-735.
- Kim JH, Choi JY, Koh SB, et al. Reversible splenial abnormality
in hypoglycemic encephalopathy. Neuroradiology 2007;49(3):
217-222.
- Sawagashira R, Narita H, Hashimoto N, et al. Transient
lesions of the splenium of the corpus callosum following rapid
withdrawal of levetiracetam. Epileptic Disord 2017;19: 379-
382.
- Förster A, Apfaltrer P, Al-Zghloul M, et al. Diffusion Restricted
Lesions in the Splenium of the Corpus Callosum. In vivo 2022:
36: 1354-1359